Fabrication and characterization of UV-emitting nanoparticles as novel radiation sensitizers targeting hypoxic tumor cells

Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers-New Aspects and Revelations

This work investigates the proposed enhanced efficacy of photodynamic therapy (PDT) by activating photosensitizers (PSs) with Cherenkov light (CL). The approaches of Yoon et al. to test the effect of CL with external radiation were taken up and refined. The results were used to transfer the applied scheme from external radiation therapy to radionuclide therapy in nuclear medicine. Here, the CL for the activation of the PSs (psoralen and trioxsalen) is generated by the ionizing radiation from rhenium-188 (a high-energy beta-emitter, Re-188). In vitro cell survival studies were performed on FaDu, B16 and 4T1 cells. A characterization of the PSs (absorbance measurement and gel electrophoresis) and the CL produced by Re-188 (luminescence measurement) was performed as well as a comparison of clonogenic assays with and without PSs. The methods of Yoon et al. were reproduced with a beam line at our facility to validate their results. In our studies with different concentrations of PS and considering the negative controls without PS, the statements of Yoon et al. regarding the positive effect of CL could not be confirmed. There are slight differences in survival fractions, but they are not significant when considering the differences in the controls. Gel electrophoresis showed a dominance of trioxsalen over psoralen in conclusion of single and double strand breaks in plasmid DNA, suggesting a superiority of trioxsalen as a PS (when irradiated with UVA). In addition, absorption measurements showed that these PSs do not need to be shielded from ambient light during the experiment. An observational test setup for a PDT nuclear medicine approach was found. The CL spectrum of Re-188 was measured. Fluctuating inconclusive results from clonogenic assays were found.

Optical and thermal properties of rare earth-doped K4 Ca(PO4 )2 phosphor

The luminescent properties and energy transfer (ET) mechanism in the Ln³⁺ pair of the RE³⁺ (RE = Eu³⁺ , Ce³⁺ , Dy³⁺ and Sm³⁺ ) doped K₄ Ca(PO₄ )₂ phosphor were successfully investigated using a conventional high-temperature solid-state reaction. In the near infrared (NIR) range, Ce³⁺ -doped K₄ Ca(PO₄ )₂ phosphor exhibited a UV-Vis. emission band, whereas K₄ Ca(PO₄ )₂ :Dy³⁺ exhibited characteristic emission bands centred at 481 and 576 nm in the near-ultraviolet excitation range. The possibility of ET from Ce³⁺ to Dy³⁺ in K₄ Ca(PO₄ )₂ phosphor was confirmed by a significant increase in the photoluminescence intensity of the Dy³⁺ ion based on the spectral overlap of acceptor and donor ions. X-ray diffraction, Fourier-transform infrared and thermogravimetric analysis/differential thermal analysis TGA/DTA were carried out to study phase purity, presence of functional groups and amount of weight loss under different temperature regimes. Therefore, the RE³⁺ -doped K₄ Ca(PO₄ )₂ phosphor may be a stable phosphor host for light-emitting diode applications.

Psoralen as a Photosensitizers for Photodynamic Therapy by Means of In Vitro Cherenkov Light

Possible enhancements of DNA damage with light of different wavelengths and ionizing radiation (Rhenium-188-a high energy beta emitter (Re-188)) on plasmid DNA and FaDu cells via psoralen were investigated. The biophysical experimental setup could also be used to investigate additional DNA damage due to photodynamic effects, resulting from Cherenkov light. Conformational changes of plasmid DNA due to DNA damage were detected and quantified by gel electrophoresis and fluorescent staining. The clonogene survival of the FaDu cells was analyzed with colony formation assays. Dimethyl sulfoxide was chosen as a chemical modulator, and Re-188 was used to evaluate the radiotoxicity and light (UVC: λ = 254 nm and UVA: λ = 366 nm) to determine the phototoxicity. Psoralen did not show chemotoxic effects on the plasmid DNA or FaDu cells. After additional treatment with light (only 366 nm-not seen with 254 nm), a concentration-dependent increase in single strand breaks (SSBs) was visible, resulting in a decrease in the survival fraction due to the photochemical activation of psoralen. Whilst UVC light was phototoxic, UVA light did not conclude in DNA strand breaks. Re-188 showed typical radiotoxic effects with SSBs, double strand breaks, and an overall reduced cell survival for both the plasmid DNA and FaDu cells. While psoralen and UVA light showed an increased toxicity on plasmid DNA and human cancer cells, Re-188, in combination with psoralen, did not provoke additional DNA damage via Cherenkov light.

Radiation Dose-Enhancement Is a Potent Radiotherapeutic Effect of Rare-Earth Composite Nanoscintillators in Preclinical Models of Glioblastoma

To improve the prognosis of glioblastoma, innovative radiotherapy regimens are required to augment the effect of tolerable radiation doses while sparing surrounding tissues. In this context, nanoscintillators are emerging radiotherapeutics that down-convert X-rays into photons with energies ranging from UV to near-infrared. During radiotherapy, these scintillating properties amplify radiation-induced damage by UV-C emission or photodynamic effects. Additionally, nanoscintillators that contain high-Z elements are likely to induce another, currently unexplored effect: radiation dose-enhancement. This phenomenon stems from a higher photoelectric absorption of orthovoltage X-rays by high-Z elements compared to tissues, resulting in increased production of tissue-damaging photo- and Auger electrons. In this study, Geant4 simulations reveal that rare-earth composite LaF3:Ce nanoscintillators effectively generate photo- and Auger-electrons upon orthovoltage X-rays. 3D spatially resolved X-ray fluorescence microtomography shows that LaF3:Ce highly concentrates in microtumors and enhances radiotherapy in an X-ray energy-dependent manner. In an aggressive syngeneic model of orthotopic glioblastoma, intracerebral injection of LaF3:Ce is well tolerated and achieves complete tumor remission in 15% of the subjects receiving monochromatic synchrotron radiotherapy. This study provides unequivocal evidence for radiation dose-enhancement by nanoscintillators, eliciting a prominent radiotherapeutic effect. Altogether, nanoscintillators have invaluable properties for enhancing the focal damage of radiotherapy in glioblastoma and other radioresistant cancers.

Solar-blind ultraviolet-C persistent luminescence phosphors

Visible-light and infrared-light persistent phosphors are extensively studied and are being used as self-sustained glowing tags in darkness. In contrast, persistent phosphors for higher-energy, solar-blind ultraviolet-C wavelengths (200-280 nm) are lacking. Also, persistent tags working in bright environments are not available. Here we report five types of Pr3+-doped silicates (melilite, cyclosilicate, silicate garnet, oxyorthosilicate, and orthosilicate) ultraviolet-C persistent phosphors that can act as self-sustained glowing tags in bright environments. These ultraviolet-C persistent phosphors can be effectively charged by a standard 254 nm lamp and emit intense, long-lasting afterglow at 265-270 nm, which can be clearly monitored and imaged by a corona camera in daylight and room light. Besides thermal-stimulation, in bright environments, photo-stimulation also contributes to the afterglow emission and its contribution can be dominant when ambient light is strong. This study expands persistent luminescence research to the ultraviolet-C wavelengths and brings persistent luminescence applications to light.

UVC-Emitting LuPO4:Pr3+ Nanoparticles Decrease Radiation Resistance of Hypoxic Cancer Cells

Radiation-resistant hypoxic tumor areas continue to present a major limitation for successful tumor treatment. To overcome this radiation resistance, an oxygen-independent treatment is proposed using UVC-emitting LuPO₄:Pr³⁺ nanoparticles (NPs) and X rays. The uptake of the NPs as well as their effect on cell proliferation was investigated on A549 lung cancer cells by using inverted time-lapse microscopy and transmission electron microscopy. Furthermore, cytotoxicity of the combined treatment of X rays and LuPO₄:Pr³⁺ NPs was assessed under normoxic and hypoxic conditions using the colony formation assay. Transmission electron microscopy (TEM) images showed no NP uptake after 3 h, whereas after 24 h incubation an uptake of NPs was documented. LuPO₄:Pr³⁺ NPs alone caused a concentration-independent cell growth delay within the first 60 h of incubation. The combined treatment with UVC-emitting NPs and X rays reduced the radiation resistance of hypoxic cells by a factor of two to the level of cells under normoxic condition. LuPO₄:Pr³⁺ NPs cause an early growth delay but no cytotoxicity for the tested concentration. The combination of these NPs with X rays increases cytotoxicity of normoxic and hypoxic cancer cells. Hypoxic cells become sensitized to normoxic cell levels.

Colloidal LaPO4:Gd3+ nanocrystals: X-ray induced single line UV emission

Colloidal solutions of nearly monodisperse 5 nm LaPO₄:Gd³⁺ nanocrystals are shown to strongly emit UV radiation upon excitation with tungsten Kα radiation (59.3 keV) or vacuum UV radiation (160 nm). The UV emission of the particles consists mainly of a single line at 311 nm corresponding to the ⁶P_7/2-⁸S_7/2 transition of Gd³⁺. The highest emission intensity is observed for LaPO₄ nanocrystals with a Gd³⁺ concentration of 20%. Since the absorption cross section of biomaterials is low for X-rays but high for 311 nm radiation, the UV emission of particles embedded in the biological tissue can only affect the direct vicinity of the particles. Nanocrystals of LaPO₄:Gd³⁺ could, therefore, be interesting for biomedical applications such as strongly localized drug release by X-ray triggered UV uncaging reactions.

UV scintillating particles as radiosensitizer enhance cell killing after X-ray excitation

BACKGROUND AND PURPOSE

Radiation therapy is the gold standard treatment for inoperable malignant tumors. However, due to the heterogeneity of the tumor, some regions are more radio resistant and can lead to metastasis and tumor recurrence. In this study, we propose combining traditional X-ray treatment with UVC-emitting LuPO4:Pr3+ nanoparticles (NPs) to increase the tumor control as well as to reduce tumor recurrence and metastasis. These NPs convert ionizing radiation into UVC-photons (UVC range: 200-280 nm) locally at the tumor site. Unlike X-ray, UVC-photons damage DNA directly via an oxygen-independent mechanism, which could improve treatment of radioresistant tumors such as hypoxic tumors.

MATERIALS AND METHODS

The effect of X-ray generated UVC-photons was tested on human fibroblasts incubated with NPs prior to radiation treatment. The surviving fraction of the cells was assessed by means of colony formation assay. Experiments were performed on normal and UVC sensitive cell lines to demonstrate the presence of UVC photons during treatment. In addition, UV-specific DNA damages were investigated using an immunofluorescence assay to measure cyclopyrimidine dimers (CPDs).

RESULTS

Combined treatment showed an increased cell death of over 50%, compared to radiation alone. This results in a dose equivalent of 4 Gy for the combined treatment with 2 Gy irradiation. The formation of CPDs and the increased effect on UV sensitive cells indicate the presence of UV photons. The generated amount of CPDs is comparable to an UVC exposure of about 15 J × m-2.

CONCLUSION

Combining NPs with ionizing radiation results in a localized dose surge, which could increase tumor control. It could also allow lowering the total applied dose to minimize unwanted side effects to the surrounding normal tissue while maintaining tumor control.